In this study, we found that C-kit, a receptor tyrosine kinase, drives EMT signaling in OA-FLSs and promotes a destructive FLS phenotype, leading to synovial inflammation and cartilage destruction, which demonstrates its translational potential as a new target in clinical treatments for patients with OA. This evidence concerns the gene NTRK1 and inflammation.